Descripción del proyecto
Integración de China en el Consorcio Internacional de Medicina Personalizada (IC2PerMed)
Gracias a los avances en las tecnologías biomédicas y digitales, la medicina personalizada mejora la atención sanitaria y promueve unos sistemas de salud más eficientes y sostenibles. En China, está atrayendo un enorme interés y el Gobierno está aprovechando sus conocimientos especializados en biotecnología, «hardware» y creación de infraestructuras para apoyar proyectos bioinformáticos. Convertir la medicina personalizada en una oportunidad para los ciudadanos y los pacientes requiere el compromiso a nivel internacional de las partes interesadas para definir de forma conjunta métodos de investigación y desarrollo, normas y prioridades. Para responder a estos retos, la Unión Europea apoya las acciones desarrolladas en el marco del Consorcio Internacional de Medicina Personalizada (ICPerMed). El proyecto financiado con fondos europeos IC2PerMed proporcionará soluciones claves para hacer posible la convergencia de las partes interesadas de Europa y China en el marco del ICPerMed de cara a un planteamiento común de la medicina personalizada que incluya a los responsables políticos y los beneficiarios de la atención sanitaria.
Objetivo
Personalised Medicine (PM) approaches, thanks to the latest technological advances notably in the fields of biomedical and digital technologies, prove their potential to improve healthcare and underpin more efficient and sustainable health systems.
PM is at the top of the European Commission research agenda, with funding devoted to projects along the entire value chain. In China, PM is attracting massive interest, with the government capitalising on its expertise in biotechnology, computing hardware and the ability to put in place the infrastructures for supporting large bioinformatics projects.
Turning PM into an opportunity for all citizens and patients requires the engagement of all stakeholders, in order to define common research and development approaches, standards, and priorities, and to scale up the collaboration at the International level. In order to respond to these challenges, the EU supports actions developed within the International Consortium for Personalised Medicine (ICPerMed).
IC2PerMed project will provide key solutions for enabling the convergence under ICPerMed consortium of European and Chinese stakeholders towards a common approach of PM research, innovation, development and implementation involving policy makers and healthcare beneficiaries, by:
- mapping policies, programmes, standards and initiatives related to PM in Europe in China for identifying the opportunities for research collaborations;
- structuring its developments upon an ecosystem of European and Chinese experts, collaborating in Working Groups centred on ICPerMed Action plan priorities;
- setting bridges with key organisms involved in the definition and implementation of PM and healthcare systems in both economic areas, both on benefits for coordinated approaches for research and on concrete developments taking place within and along the project;
- inserting its developments in international contexts, through ICPerMed and its involvement in relevant initiatives and networks.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SC1-2019-Single-Stage-RTD
Régimen de financiación
CSA - Coordination and support actionCoordinador
20123 Milano
Italia